114 related articles for article (PubMed ID: 1435485)
21. Review of negative Papanicolaou tests: is the retrospective 5-year review necessary.
Rubio CA
Am J Clin Pathol; 1994 Aug; 102(2):266. PubMed ID: 8042598
[No Abstract] [Full Text] [Related]
22. Preliminary comparison of papanicolaou smear and speculoscopy for assessing cervical cancer precursor lesions in pregnant adolescents.
Shulman LP; Klett CC; Phillips OP
J Pediatr Adolesc Gynecol; 1999 May; 12(2):78-82. PubMed ID: 10326192
[TBL] [Abstract][Full Text] [Related]
23. Papanicolaou smear.
Lipa M; Geddie W; Fletcher WA; Thompson DW; Turner-Smith L; Wood DE
CMAJ; 1994 Jun; 150(11):1756-8. PubMed ID: 8054023
[No Abstract] [Full Text] [Related]
24. Quality-assurance study of simultaneously sampled, non-correlating cervical cytology and biopsies.
Dodd LG; Sneige N; Villarreal Y; Fanning CV; Staerkel GA; Caraway NP; Silva EG; Katz RL
Diagn Cytopathol; 1993; 9(2):138-44. PubMed ID: 8513706
[TBL] [Abstract][Full Text] [Related]
25. Correlation of the Papanicolaou smear and human papillomavirus type in women with biopsy-proven cervical squamous intraepithelial lesions.
Nuovo GJ; Walsh LL; Gentile JL; Blanco JS; Koulos J; Heimann A
Am J Clin Pathol; 1991 Oct; 96(4):544-8. PubMed ID: 1654025
[TBL] [Abstract][Full Text] [Related]
26. Implementation and evaluation of a national external quality control program for cervical cytology in Mexico.
Flisser A; García-Malo F; Canepa Mde L; Doncel S; Espinoza R; Moreno R; Avila I; Pérez-Palacios G; Tapia-Conyer R; de la Fuente JR
Salud Publica Mex; 2002; 44(5):431-6. PubMed ID: 12389486
[TBL] [Abstract][Full Text] [Related]
27. Why more is not always better: new Pap smear guidelines.
Vegunta S; Kransdorf LN; Mayer AP
J Womens Health (Larchmt); 2014 Jan; 23(1):105-6. PubMed ID: 24325612
[No Abstract] [Full Text] [Related]
28. On the performance and cost-effectiveness of semiautomated Papanicolaou smear screening.
Vooijs GP
Cancer; 1998 Oct; 84(5):269-72. PubMed ID: 9801200
[No Abstract] [Full Text] [Related]
29. Cervical cancer screening: the Pap smear. Summary of an NIH consensus statement.
Br Med J; 1980 Nov; 281(6250):1264-6. PubMed ID: 7427661
[No Abstract] [Full Text] [Related]
30. Management of the abnormal Papanicolaou smear.
Appleby J
Med Clin North Am; 1995 Mar; 79(2):345-60. PubMed ID: 7877395
[TBL] [Abstract][Full Text] [Related]
31. [Quality of vaginal smear for cervical cancer screening: a concordance study].
Cendales R; Wiesner C; Murillo RH; Piñeros M; Tovar S; Mejía JC
Biomedica; 2010; 30(1):107-15. PubMed ID: 20890555
[TBL] [Abstract][Full Text] [Related]
32. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
[TBL] [Abstract][Full Text] [Related]
33. Interobserver variability of a Papanicolaou smear diagnosis of atypical glandular cells of undetermined significance.
Raab SS; Geisinger KR; Silverman JF; Thomas PA; Stanley MW
Am J Clin Pathol; 1998 Nov; 110(5):653-9. PubMed ID: 9802352
[TBL] [Abstract][Full Text] [Related]
34. The Pap smear is a cancer screening test: why not put the screening error rate in the report?
Robb J
Diagn Cytopathol; 1993 Oct; 9(5):485-6. PubMed ID: 8054009
[No Abstract] [Full Text] [Related]
35. Papanicolaou smear cell recovery techniques used by primary care physicians.
Clement KD; Christenson PD
J Am Board Fam Pract; 1990; 3(4):253-8. PubMed ID: 2248091
[TBL] [Abstract][Full Text] [Related]
36. The preparation of additional smears from a cervical scrape: impact on the rate of detection of cervical neoplasia.
Al-Awadhi R; Byrne M; Coleman DV
Cytopathology; 2001 Jun; 12(3):151-6. PubMed ID: 11380556
[TBL] [Abstract][Full Text] [Related]
37. Daily peer review of abnormal cervical smears in the assessment of individual practice as an additional method of internal quality control.
Confortini M; Di Stefano C; Biggeri A; Bulgaresi P; Di Claudio G; Grisotto L; Maddau C; Matucci M; Petreschi C; Troni GM; Turco P; Foxi P
Cytopathology; 2016 Feb; 27(1):35-42. PubMed ID: 25123613
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
Koss LG; Lin E; Schreiber K; Elgert P; Mango L
Am J Clin Pathol; 1994 Feb; 101(2):220-9. PubMed ID: 8116579
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of Ki-67 antigen staining in Papanicolaou (Pap) smears in post-menopausal women with atypia--an audit.
Ejersbo D; Jensen HA; Hølund B
Cytopathology; 1999 Dec; 10(6):369-74. PubMed ID: 10607007
[TBL] [Abstract][Full Text] [Related]
40. Follow-up of unsatisfactory Papanicolaou test results.
McGaraghan A; Smith-McCune K
JAMA; 2000 Mar; 283(10):1290-1. PubMed ID: 10714724
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
